Prompt and specialized treatment is necessary for serious medical conditions such as high blood pressure and heart failure. Recent investigations have revealed that Valsartan, commonly prescribed for these conditions, may contain impurities linked to cancer. If you or a loved one has developed cancer after taking Valsartan medication, considering legal action through the Valsartan Cancer Lawsuits may be prudent.
What is Valsartan, and why is it being recalled?
Valsartan, a generic drug utilized in the treatment of high blood pressure and heart failure, has become a necessity for many Americans. However, its association with severe side effects like cancer has raised concerns. Various contaminants found within the pills have been the cause, and the unsuspecting consumers of Valsartan have initiated a class-action lawsuit against its manufacturers in recent months.
Manufacturers Involved and FDA Advisory
Major Pharmaceuticals, Solco Healthcare, and Teva Pharmaceuticals manufactured the affected medications. The FDA recommended that patients consult their healthcare providers for alternative medication options due to this. The recall also led to increased scrutiny of manufacturing processes and quality control among FDA-approved drug manufacturers.
As a result, individuals have filed legal actions against the manufacturers. Patients who allege that they developed cancer from the contaminated drugs are seeking compensation for medical bills, lost income, pain and suffering, and other damages. These lawsuits accuse the manufacturers of negligence in handling and distributing the medication. They also claim that the manufacturers failed to communicate the risks to patients and doctors.
Additional Recalls and Continued Concerns
The FDA initially announced the Valsartan recall in July 2018. Since then, there have been additional recalls of Valsartan medications, including various generic brands. Multiple pharmaceutical companies manufacture Valsartan. The ongoing concern persists regarding contamination with cancer-causing substances such as N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA).
The contamination of Valsartan medication poses a serious risk of cancer for patients. The International Agency for Research on Cancer (IARC) classifies NDMA as a probable human carcinogen. It has been linked to various types of cancer, including stomach and liver cancer. Similarly, NDEA has also been classified as a probable human carcinogen and has been linked to liver, lung, and bladder cancer.
Obtain the Justice & Compensation You Deserve
If you have received a cancer diagnosis after taking prescribed Valsartan medication, you may feel overwhelmed. At Gallon, Takacs & Boissoneault, our professional Valsartan Cancer Lawsuit attorneys understand the challenges that unexpected medical issues can bring. We have extensive expertise in handling defective drug claims, especially those related to Valsartan. Our firm is committed to providing individualized attention and conducting comprehensive evaluations for each client. By reviewing your medical records, we will assess whether pursuing a legal case is in your best interest. Our goal is to secure the justice and compensation you deserve. Let us help you navigate this challenging period and guide you toward the best course of action for your circumstances. Contact us today at 419-843-6663 or use our online contact form.
